Putnam Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$10.1M Sell
31,394
-16,512
-34% -$5.33M 0.01% 324
2023
Q3
$17.2M Sell
47,906
-1,618
-3% -$580K 0.03% 231
2023
Q2
$18.8M Sell
49,524
-84,664
-63% -$32.1M 0.03% 217
2023
Q1
$64.3M Buy
134,188
+9,204
+7% +$4.41M 0.1% 138
2022
Q4
$52.6M Buy
124,984
+31,940
+34% +$13.4M 0.09% 142
2022
Q3
$38.8M Buy
93,044
+48,237
+108% +$20.1M 0.07% 153
2022
Q2
$22.2M Buy
44,807
+8,285
+23% +$4.1M 0.04% 199
2022
Q1
$20.6M Sell
36,522
-35,673
-49% -$20.1M 0.03% 221
2021
Q4
$54.5M Sell
72,195
-6,280
-8% -$4.74M 0.08% 155
2021
Q3
$58.5M Buy
78,475
+296
+0.4% +$221K 0.09% 158
2021
Q2
$50.4M Buy
78,179
+1,060
+1% +$683K 0.08% 167
2021
Q1
$44M Sell
77,119
-18,806
-20% -$10.7M 0.07% 182
2020
Q4
$55.9M Sell
95,925
-6,599
-6% -$3.85M 0.1% 160
2020
Q3
$52.8M Sell
102,524
-8,915
-8% -$4.6M 0.1% 153
2020
Q2
$50.3M Buy
111,439
+62,870
+129% +$28.4M 0.11% 149
2020
Q1
$17M Buy
48,569
+32,990
+212% +$11.6M 0.04% 233
2019
Q4
$5.76M Buy
15,579
+501
+3% +$185K 0.01% 480
2019
Q3
$5.02M Hold
15,078
0.01% 503
2019
Q2
$4.71M Buy
15,078
+600
+4% +$188K 0.01% 531
2019
Q1
$4.43M Sell
14,478
-115,353
-89% -$35.3M 0.01% 542
2018
Q4
$30.2M Sell
129,831
-9,987
-7% -$2.32M 0.08% 195
2018
Q3
$43.8M Buy
139,818
+9,447
+7% +$2.96M 0.09% 174
2018
Q2
$37.6M Sell
130,371
-6,500
-5% -$1.88M 0.09% 195
2018
Q1
$34.2M Sell
136,871
-108,114
-44% -$27M 0.08% 210
2017
Q4
$58.5M Buy
244,985
+23,960
+11% +$5.72M 0.13% 159
2017
Q3
$49.1M Buy
221,025
+8,934
+4% +$1.99M 0.11% 162
2017
Q2
$48M Buy
212,091
+118,840
+127% +$26.9M 0.11% 166
2017
Q1
$18.6M Buy
+93,251
New +$18.6M 0.04% 292
2016
Q3
Sell
-12,885
Closed -$1.84M 1266
2016
Q2
$1.84M Buy
12,885
+150
+1% +$21.5K ﹤0.01% 955
2016
Q1
$1.74M Sell
12,735
-878
-6% -$120K ﹤0.01% 986
2015
Q4
$1.89M Buy
13,613
+991
+8% +$137K ﹤0.01% 991
2015
Q3
$1.7M Buy
+12,622
New +$1.7M ﹤0.01% 1033